Acceleration and Intensification of Cell Culture-Produced Influenza Vaccines for Rapid Response to Pandemic Situation

加速和强化细胞培养生产的流感疫苗，以快速应对大流行情况

• 批准号: 361102
• 负责人: Kamen Amine
• 金额: $ 27.07万
• 依托单位: McGill University
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2016
• 资助国家: 加拿大
• 起止时间: 2016-10-01 至 2019-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=361102&lang=en
• 关键词: Bioprocess Development; Cell Culture Engineering; Cell/Virus Interaction; Immunogenicity Studies In Animals; Influenza Virus; Pandemic Situation; Potency Assays; Process Analytical Tecchnology; Vaccine; Vaccine Manufacturing

Over the last decades, significant investments have been directed by the US Department of Health and other national and international authorities to build capacities and implement preparedness plans to face influenza pandemic situations. During influenza

在过去的几十年里，美国卫生部和其他国家和国际当局已经进行了大量投资，以建立能力和实施应对流感大流行情况的准备计划。流感期间